YahooOctober 22, 2026 at 11:07 AM NY5 Days Ago
Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says
Abbott Laboratories' (ABT) 2026 guidance cuts were driven by headwinds related to its diabetes and e
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
